Cause of death
| n (%) . | All (N = 413) . | Group I . | Group II . | Group III . | Group IV . |
|---|---|---|---|---|---|
| CNI-MTX (n = 210) . | ATG-CNI-MTX (n = 34) . | PTCy-ATG-CNI (n = 78) . | PTCy-CNI- MMF (n = 91) . | ||
| Relapse | 86 (43) | 39 (45.4) | 12 (13.9) | 20 (23.3) | 15 (17.4) |
| Infections | 54 (27) | 31 (57.4) | 6 (11.1) | 13 (24.1) | 4 (7.4) |
| GVHD | 45 (22.5) | 33 (73.3) | 6 (13.3) | 5 (11.1) | 1 (2.2) |
| Cardiac events | 9 (4.5) | 9 (100) | 0 | 0 | 0 |
| Veno-occlusive disease | 6 (3) | 3 (50) | 0 | 2 (33.3) | 1 (16.7) |
| n (%) . | All (N = 413) . | Group I . | Group II . | Group III . | Group IV . |
|---|---|---|---|---|---|
| CNI-MTX (n = 210) . | ATG-CNI-MTX (n = 34) . | PTCy-ATG-CNI (n = 78) . | PTCy-CNI- MMF (n = 91) . | ||
| Relapse | 86 (43) | 39 (45.4) | 12 (13.9) | 20 (23.3) | 15 (17.4) |
| Infections | 54 (27) | 31 (57.4) | 6 (11.1) | 13 (24.1) | 4 (7.4) |
| GVHD | 45 (22.5) | 33 (73.3) | 6 (13.3) | 5 (11.1) | 1 (2.2) |
| Cardiac events | 9 (4.5) | 9 (100) | 0 | 0 | 0 |
| Veno-occlusive disease | 6 (3) | 3 (50) | 0 | 2 (33.3) | 1 (16.7) |